NNNN
Anbio Biotechnology
4.05
+0.25 (+6.58%)
52w low 3.09
44.73 high
2.3% of range
Financial Analysis
| (USD) | Dec 21 | Dec 22 | Dec 23 | Dec 24 | Dec 25 | Trend |
|---|---|---|---|---|---|---|
| Cash & Equivalents | -- | 7.10M | 9.69M | 11.76M | 7.77M | |
| Receivables | -- | 0.00 | 1.88M | 1.06M | 3.66M | |
| Inventory | 0.00 | 353.87K | 0.00 | -- | -- | |
| Current Assets | -- | 13.94M | 15.75M | 18.53M | 30.24M | |
| Net PP&E | 0.00 | 12.06K | -- | -- | -- | |
| Total Assets | -- | 13.96M | 15.81M | 18.92M | 30.24M | |
| Current Liabilities | -- | 1.41M | 993.06K | 1.73M | 87.84K | |
| Total Liabilities | -- | 1.41M | 993.06K | 1.73M | 87.84K | |
| Retained Earnings | -- | 12.55M | 14.80M | 17.17M | 23.58M | |
| Shareholders Equity | -- | 12.55M | 14.82M | 17.19M | 30.16M | |
| Working Capital | -- | 12.53M | 14.76M | 16.80M | 30.16M | |
| Shares Outstanding | -- | 43.89M | 43.89M | 43.89M | 43.89M |
Revenue CAGR
-28.4%
Net Income CAGR
-13.8%
EPS CAGR
+28.7%
FCF CAGR
--
Revenue YoY
+5.6%